Baxion
ScreeningTagsAlerts

Generate Biomedicines, Inc.

GENB·NASDAQ·$13.34Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/06/2610-QQuarter ended 03/31/2605/07/26

Disclosures

8-KCurrent report08/26/268-KCurrent report08/06/268-KResults of Operations05/07/268-KAmendments to Articles or Bylaws03/02/26

Prospectuses and Registrations

424B4Prospectus02/27/26S-8Registration of securities for employees02/27/26S-1/ARegistration statement (amended)02/23/26S-1/ARegistration statement (amended)02/13/26S-1Registration statement (IPO)02/04/26

Proxies

No matching filings.

Ownership

144Proposed sale of securities10/29/26Form 4Insider transaction09/03/26144Proposed sale of securities09/02/26144Proposed sale of securities09/01/26SC 13GBeneficial ownership05/15/26

Other

CERTCEO/CFO certification02/26/26EFFECTRequest for effectiveness02/26/268-A12B8-A12B02/24/26DRSDRS12/23/25

Latest Filings

8-KCurrent report08/26/2610-QQuarter ended 06/30/2608/06/268-KCurrent report08/06/2610-QQuarter ended 03/31/2605/07/268-KResults of Operations05/07/26

Ownership

144Proposed sale of securities10/29/26Form 4Insider transaction09/03/26144Proposed sale of securities09/02/26144Proposed sale of securities09/01/26SC 13GBeneficial ownership05/15/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact